Pages that link to "Q38006131"
Jump to navigation
Jump to search
The following pages link to Inhibition of interleukin-5 for the treatment of eosinophilic diseases (Q38006131):
Displaying 24 items.
- Biological Treatments in Atopic Dermatitis (Q26799579) (← links)
- Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice (Q30543593) (← links)
- Phenome-wide association study (PheWAS) in EMR-linked pediatric cohorts, genetically links PLCL1 to speech language development and IL5-IL13 to Eosinophilic Esophagitis (Q34531775) (← links)
- Plasma IL-5 concentration and subclinical carotid atherosclerosis (Q35122015) (← links)
- Eosinophils and megakaryocytes support the early growth of murine MOPC315 myeloma cells in their bone marrow niches (Q35291672) (← links)
- Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease (Q35699974) (← links)
- Preventive effect of N-acetylcysteine in a mouse model of steroid resistant acute exacerbation of asthma. (Q35937839) (← links)
- Adaptive immunity in atherogenesis: new insights and therapeutic approaches (Q36497196) (← links)
- Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury (Q36829834) (← links)
- Eosinophils in vasculitis: characteristics and roles in pathogenesis (Q36847447) (← links)
- Protective effect of soybean oil- or fish oil-rich diets on allergic airway inflammation (Q36926839) (← links)
- Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan (Q37166692) (← links)
- Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers (Q37551110) (← links)
- Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma (Q38074647) (← links)
- Meta-analyses of four eosinophil related gene variants in coronary heart disease (Q38074824) (← links)
- The Eosinophil in Health and Disease: from Bench to Bedside and Back (Q38593724) (← links)
- Targeted Therapy for Older Patients with Uncontrolled Severe Asthma: Current and Future Prospects (Q38820261) (← links)
- IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation. (Q40172237) (← links)
- A new combination therapy for asthma using dual-function dexamethasone-conjugated polyethylenimine and vitamin D binding protein siRNA. (Q45871249) (← links)
- Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis (Q47785190) (← links)
- Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease. (Q52719312) (← links)
- Anti-inflammatory effect of wogonin on allergic responses in ovalbumin-induced allergic rhinitis in the mouse. (Q55517298) (← links)
- Long non-coding RNAs in immune regulation and their potential as therapeutic targets (Q89717338) (← links)
- Asthma: A Loss of Post-natal Homeostatic Control of Airways Smooth Muscle With Regression Toward a Pre-natal State (Q94564218) (← links)